Tampere Traumatic Head and Brain Injury Study
TheBrainS
1 other identifier
observational
115
1 country
1
Brief Summary
Tampere Traumatic head and brain injury study is a prospective study aiming to explore neuroradiological, neuropsychological, neurological and biochemical aspects of mild traumatic brain injury (mtbi). The main interest is on factors that effect to the outcome after mtbi. The study is conducted in Tampere University Hospital's emergency department between the 1st of August 2010 and 31st of July 2013.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 1, 2011
CompletedFirst Posted
Study publicly available on registry
September 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedOctober 6, 2021
October 1, 2021
10.3 years
September 1, 2011
October 5, 2021
Conditions
Eligibility Criteria
Community sample consisting of consecutive mild traumatic brain injury patients metting the enrollment criteria.
You may qualify if:
- WHO's mtbi criteria
- Inhabitant of Pirkanmaa hospital district
- Age between 18 and 60 years
You may not qualify if:
- Detrimental alcohol use
- Drug addiction
- Chronic neurological disease
- Earlier brain injury
- Diagnosed psychiatric disease
- Hearing or sight deficiency
- Native language other than finnish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampere University Hospital
Tampere, 33521, Finland
Biospecimen
1. 10ml whole blood 2. 10ml EDTA-blood x2
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Teemu M. Luoto, M.D.
Tampere University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Researcher
Study Record Dates
First Submitted
September 1, 2011
First Posted
September 2, 2011
Study Start
November 1, 2010
Primary Completion
February 1, 2021
Study Completion
February 1, 2021
Last Updated
October 6, 2021
Record last verified: 2021-10